Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MLAB 
Mesa Laboratories Inc (MLAB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: MLAB (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $88.5
1 Year Target Price $88.5
| 2 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -52.53% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 411.89M USD | Price to earnings Ratio - | 1Y Target Price 88.5 |
Price to earnings Ratio - | 1Y Target Price 88.5 | ||
Volume (30-day avg) 4 | Beta 0.91 | 52 Weeks Range 55.32 - 154.33 | Updated Date 11/7/2025 |
52 Weeks Range 55.32 - 154.33 | Updated Date 11/7/2025 | ||
Dividends yield (FY) 0.86% | Basic EPS (TTM) -0.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-06 | When - | Estimate 2.3 | Actual - |
Profitability
Profit Margin -0.26% | Operating Margin (TTM) 5.15% |
Management Effectiveness
Return on Assets (TTM) 2.04% | Return on Equity (TTM) -0.38% |
Valuation
Trailing PE - | Forward PE 35.21 | Enterprise Value 568237582 | Price to Sales(TTM) 1.7 |
Enterprise Value 568237582 | Price to Sales(TTM) 1.7 | ||
Enterprise Value to Revenue 2.34 | Enterprise Value to EBITDA 12.54 | Shares Outstanding 5501454 | Shares Floating 5324197 |
Shares Outstanding 5501454 | Shares Floating 5324197 | ||
Percent Insiders 5.5 | Percent Institutions 92.85 |
Upturn AI SWOT
Mesa Laboratories Inc
Company Overview
History and Background
Mesa Laboratories, Inc. was founded in 1982. Initially focused on providing quality control equipment and services to the pharmaceutical industry, it has expanded through strategic acquisitions and organic growth to offer a wider range of products and services related to sterilization, disinfection, and analytical quality control.
Core Business Areas
- Sterilization and Disinfection Control: Develops and manufactures biological indicators (BIs), chemical indicators (CIs), and process challenge devices (PCDs) used to monitor sterilization and disinfection processes in healthcare, pharmaceutical, and industrial settings.
- Continuous Monitoring: Provides real-time monitoring systems for environmental parameters such as temperature, humidity, and differential pressure, primarily used in pharmaceutical manufacturing and other controlled environments.
- Instruments: Offers a range of precision measurement instruments, including calibrators, flow meters, and sensors, used for various industrial and scientific applications.
- Consumables: Production of consumable products for cleaning and sterilization
Leadership and Structure
The leadership team includes the CEO, CFO, and various VPs heading different business units. The organizational structure is typically hierarchical, with functional departments supporting the core business segments. The current CEO is Gary Owens. The CFO is John Sakys.
Top Products and Market Share
Key Offerings
- Biological Indicators (BIs): BIs are used to monitor sterilization processes. Mesa Labs is a leading supplier in this market. Competitors include STERIS Corporation and 3M. Market share is approximately 30% in the BI market segment.
- DataTrace: DataTrace is a real-time monitoring system used in pharmaceutical manufacturing. Competitors include Vaisala and Kaye (part of Amphenol). Mesa aims to increase its share in this market to greater than 10%.
- Apex Indicators: Apex chemical indicators, are used to determine if certain conditions for sterilization were met. Compettitors include STERIS Corporation and 3M. Market share is approximately 20% in the Apex market segment.
Market Dynamics
Industry Overview
The sterilization and disinfection control market is driven by stringent regulations, increasing healthcare-associated infections (HAIs), and the growing demand for sterile products in various industries. The market is expected to grow moderately in the coming years.
Positioning
Mesa Laboratories Inc is positioned as a leading provider of quality control solutions, with a strong focus on innovation and regulatory compliance. Their competitive advantage lies in their comprehensive product portfolio and expertise in sterilization and disinfection monitoring.
Total Addressable Market (TAM)
The TAM for sterilization and disinfection control is estimated to be around $3 billion globally. Mesa Laboratories Inc has a potential of approimately 10% of this market.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Comprehensive product portfolio
- Expertise in regulatory compliance
- Established customer base
- High gross margins
Weaknesses
- Dependence on regulatory approvals
- Limited geographic presence compared to larger competitors
- Integration challenges with acquired companies
- Small company compared to competitors
Opportunities
- Expanding into emerging markets
- Developing new products and services for emerging applications
- Acquiring complementary businesses
- Capitalizing on increasing regulatory scrutiny
Threats
- Increased competition from larger players
- Changes in regulatory requirements
- Economic downturn affecting capital spending
- Product liability claims
Competitors and Market Share
Key Competitors
- STERIS (STE)
- 3M (MMM)
- Cantel Medical (Formerly CANT) (Now part of STERIS (STE))
Competitive Landscape
Mesa Labs is a smaller player compared to STERIS and 3M, but it has a strong niche focus on sterilization and disinfection control. Mesa Labs competes on product quality, innovation, and customer service.
Major Acquisitions
Biological Controls, Inc.
- Year: 2021
- Acquisition Price (USD millions): 30
- Strategic Rationale: Expanded Mesa's biological indicator product line and customer base.
Glocon Inc.
- Year: 2023
- Acquisition Price (USD millions): 18.5
- Strategic Rationale: Expanded Mesa's offerings of data acquisition and control products.
Growth Trajectory and Initiatives
Historical Growth: Mesa Laboratories Inc has achieved strong growth through both organic initiatives and strategic acquisitions.
Future Projections: Analysts project continued growth for Mesa Labs, driven by increasing demand for sterilization and disinfection control products. Projected growth is approximately 7% annually.
Recent Initiatives: Recent initiatives include expanding into new markets (such as Europe), developing new products for the pharmaceutical industry, and optimizing operations to improve profitability.
Summary
Mesa Laboratories Inc. is a strong company with a focus on niche markets for sterilization and disinfection controls. Their financial performance continues to show high gross margins and consistent revenue growth. Areas to look out for include regulatory changes and integration challenges with acquired companies, with increasing competition from larger players.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC Filings (10-K, 10-Q)
- Company Website
- Analyst Reports (where available)
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share data is approximate and based on available industry reports. Financial data is based on historical performance and does not guarantee future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mesa Laboratories Inc
Exchange NASDAQ | Headquaters Lakewood, CO, United States | ||
IPO Launch date 1995-01-25 | CEO, President & Director Mr. Gary M. Owens | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 730 | Website https://www.mesalabs.com |
Full time employees 730 | Website https://www.mesalabs.com | ||
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.